NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
22 hedge funds and large institutions have $340K invested in NeuBase Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.32%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
3
Increased
3
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
TSS
1
Two Sigma Securities
New York
|
$0 |
2 |
KAS
2
Kestra Advisory Services
Austin,
Texas
|
$12.2K |
3 |
3
BlackRock
New York
|
$62 |
4 |
4
First Manhattan
New York
|
$261 |